Ezetimibe important intermediate synthetic method

The invention relates to a synthetic method of an ezetimibe important intermediate shown in a formula I, and the ezetimibe important intermediate is obtained by a catalytic reduction method of an asymmetric ruthenium catalyst. The synthetic method has high yield, a diastereoisomer is controllable, the cost is low, and the large industrial production can be easily realized.